Purpose. Trends in the use of different treatments for osteoporosis among the civilian, ambulatory U.S. population are described. Methods. Data from the Medical Expenditure Panel Survey (MEPS) were ...

For decades, the first-line treatment for osteoporosis was a type of medication called antiresorptive agents, which work by slowing down the rate of bone loss. Now, though, theres a newer treatment ...

Over the last decade, goal-directed management of osteoporosis has been developed as a concept. In 2024, a working group of ...

Researchers at the University of São Paulo (USP) in Brazil have discovered that two osteoporosis drugs (etidronate and tiludronate) may combat diseases caused by iron accumulation in the body. In ...

(Reuters Health) - Women with osteoporosis who take drugs to help avoid fractures still need to have their bone density monitored, a Canadian study suggests. Researchers who studied more than 6,600 ...

A $7 million study beginning this summer at Wake Forest University and Wake Forest University School of Medicine will help determine whether a combination of resistance training plus ...

Science and society collaboration is essential for scientific progress, especially in the health and biomedical fields where basic researchers, clinicians and patients are involved, as shown by the ...

City of Hope ®, one of the largest and most advanced cancer research and treatment organizations in the United States and a top research center for diabetes and other life-threatening illnesses, is ...

A research team from the Department of Pharmacology and Pharmacy, LKS Faculty of Medicine of the University of Hong Kong (HKUMed), has found that nitrogen-containing bisphosphonates (NBPs), a ...

HKUMed revealed that widely used osteoporosis medications—nitrogen-containing bisphosphonates, may significantly reduce the risk of Alzheimer’s disease and related dementias in older adults with ...

LOS ANGELES - With the launch of the first prescription osteoporosis medication 15 years ago, millions of Americans with the bone-thinning disease began taking the drugs and never looked back. But now ...

Figure 1 shows annual osteoporosis prevalence and treatment estimates from MEPS years 1999 to 2005 among the sample of patients ages 50 years and older who self-reported osteoporosis. Self-report of ...